June 23rd, 2017, Friday

Grand Ballroom

12:00 PM - 1:00 PM   Check-in

1:00 PM - 1:10 PM   Welcome Remarks

Bin Shi, PhD, President, SAPA‐GP; Head of External R&D/Licensing, Amgen Asia R&D Center

1:10 PM - 1:30 PM   Presidential Election Speeches                                                              

Zhenhua Wu, PhD, President-Elect, SAPA-GP; Associate Director, GlaxoSmithKline

 

Featured Presentation

1:30 PM - 2:00 PM

Grand Ballroom

1:30 PM - 2:00 PM   Delivering Cell and Gene Therapy: One Big Pharma’s Approach

Joseph Tarnowski, PhD, Senior Vice President, Cell and Gene Therapy Platforms, PTS, R&D, GlaxoSmithKline

 

Plenary Session I

2:15 PM - 3:45 PM

Grand Ballroom

Big Data and Artificial Intelligence: Emerging Paradigm to Accelerate Delivery of Transformational Therapies

 Session Chairs:

Yuchen Bai, PhD, Associate Scientific Director, Johnson & Johnson

Han Dai, PhD, Scientific Leader, GSK Fellow, GlaxoSmithKline

2:15 PM - 2:45 PM   The Role of Small and Big Data in Drug Discovery       

Gunaretnam (Guna) Rajagopal, PhD, Global Head of Computational Sciences within Discovery Sciences, Janssen R&D

2:45 PM - 3:15 PM   AI for Healthcare: Challenges and Opportunities. 

Sean Zhou,PhD, Senior Director, Head of Computer Aided Detection and Diagnosis, Siemens Healthineers

3:15 PM - 3:45 PM   Construction of Biomedical Big Data Platform in Shanghai Jiaotong University and the Children Hospital of Shanghai  

Gang(Gilbert) Feng,PhD, Executive Director of the Big Data Platform in Shanghai Jiaotong University-Yale University Joint Center for Biostatistics and Senior Consultant in the National Center for Blood Disease Translational Medicine at Shanghai

3:45 PM - 4:15 PM   Coffee Break        

 

Workshop I

4:00 PM – 5:15 PM

Centennial Ballroom II

Position Yourself for the Future – Power Plan for Success

Co-organized with ASCEND,

the largest non-profit Pan-Asian organization for business professionals in North America

Session Chairs:

Haifeng Cui,PhD, GSK Fellow, Chief Scientist, GlaxoSmithKline

Hao Sun,MS, Senior Scientist, GlaxoSmithKline

4:00 PM - 4:25 PM   Optimized Potential through Emotional Intelligence

Jen Groover,Human Potential & Business Expert, Author, International Speaker, Serial Entrepreneur, TV Personality, Inventor, Advisor, Advocate, Ascend

4:25 PM - 4:50 PM   One Person, but Many Faces of Leadership: Flexing Your Style as a Leader

Sue Crimmin, PhD, Vice President, Sample Management Tech, GlaxoSmithKline

4:50 PM - 5:15 PM   What’s next?

Carolyn Buser-Doepner, PhD, Vice President, Head of Discovery Partnerships with Academia (DPAc), GlaxoSmithKline

Job Fair

2:00 PM - 5:00 PM

Centennial Ballroom I

 Session Chairs:

Meizhen Feng, MS, Associate Principle Scientist, Merck & Co.

Yu Gao,MS, Research Associate, Teva Pharmaceuticals           

VIP Session A

Frazer

2:30 PM – 4:30 PM

CEO Forum: Innovative Drug R&D in China

 

Session Chairs:

Sean Zhang, MD, FCP, Site Head, Board Member, CMO, Hengrui Therapeutics

Xue Liang, PhD, Microbiome Scientist, Merck & Co. 

2:30 PM - 4:30 PM   Panel Discussion

Mingjiu Chen, PhD, President and CEO, BioSynergics Inc.

Xu Chen, EMBA, President, ExCell Bio

Jim (Jingjun) Huang, PhD, CEO, Ascendia Pharmaceuticals

Larry Huang,PhD, President, Ark Pharm, Inc.

Feng (Frank) Li, PhD, President, Alliance Pharma

Simon Li, MD, PhD, Chief Medical Officer, Vice President of CSPC Pharma

Jay Mei, MD, PhD, Founder and CEO, Antegene Corporation

Weikang Tao, PhD, CEO of R&D Centers, Vice President, Jiangsu Hengrui Medicine Co., Ltd

Jingang Wang, EMBA, CEO, CoSci Med-Tech Co. Ltd

Philip Wang, VP, Hisun Pharmaceutical Company

Jingyi Wang, MD, PhD, President of Kelun Pharmaceutical Research Institute

Junzhi(John) Yao, PhD, co-founder and CEO, TC Scientific

Dan Zhang, MD, MPH, MA, CEO, Fountain Medical Development Ltd

Ming-Qiang Zhang,PhD,Vice President of R&D, Head of Amgen Asia R&D Center

De-Min Zhu, PhD, President and CEO, Curelong Group

 

VIP Session B

2:15 PM - 5:00 PM

Centennial Ballroom III

US-China Public Private Partnership (PPP): Biopharma Development Zones, Technology Transfer and Government Affairs

Session Chairs:

James Fendrick, BS, President and CEO, Rockland Immunochemicals, Inc.

David Cragin, PhD, Associate Director, Merck & Co. 

2:15 PM - 2:45 PM   The City of Philadelphia’s China Initiatives and Our New Developments

Lauren Swartz, BA, SeniorDirector, International Business Investment, Department of Commerce, City of Philadelphia

2:45 PM - 3:15 PM   Development of SOTIO Immunotherapy: A Czech-China Story

Vladimír Hrůša, MBA, CEO of SotioMedical Research Co.

3:15 PM - 3:45 PM   Partnering with the National Cancer Institute: An American Success Story  

James Fendrick, BS, President and CEO, Rockland Immunochemicals, Inc.

3:45 PM - 4:15 PM   Coffee Break         

4:15 PM - 5:00 PM   Panel Discussion     

John Xu, MD, MBA, MS, Senior Vice President of Strategic Alliance, AbPro

Jim (Jingjun) Huang, PhD, CEO, Ascendia Pharmaceuticals

Lauren Swartz, BA, SeniorDirector, International Business Investment, Department of Commerce, City of Philadelphia

Vladimír Hrůša, MBA, CEO of SotioMedical Research Co.

VIP Session C

2:15 PM - 5:00 PM

Harverford

US-China CRO Landscape: Building Success with Strategic Alliances

Featuring Participants from US and China CROs and Industry Executives

 Session Chairs:

Li Cui, PhD, Investigator, GlaxoSmithKline

Weifeng Tang, MD, PhD, Director, AstraZeneca Pharmaceuticals 

2:15 PM - 2:40 PM   Connecting Science to Patients: Immuno-Oncology and Translational Oncology Platforms

Michelle Mack, MS, Director of Scientific Engagement, Crown Bioscience       

2:40 PM - 3:05 PM   CRO Landscape     

Henry Lu, PhD, Vice President and Head of Biology, WuXi AppTec 

3:05 PM - 3:30 PM   Clinical Development Outsourcing

Karen Chu, Pharma D,Corporate Vice President, Clinical Research Services,Parexel 

3:30 PM – 3:55 PM   Animal Models in Drug Discovery on Immunotherapy

Jun Wang, PhD, Vice President of Biology, Shanghai Medicilon, Inc. 

3:55 PM - 4:25 PM   Coffee Break 

4:25 PM - 5:00 PM   Panel Discussion     
Russell Dahl, PhD, Vice President, Global Business Development of Sundia

Mingjiu Chen, PhD, President and CEO, BioSynergics Inc.

Michelle Mack, MS, Director of Scientific Engagement, Crown Bioscience

Henry Lu, PhD, Vice President and Head of Biology, WuXi AppTec

Karen Chu,Pharma D,Corporate Vice President, Clinical Research Services,Parexel

Jun Wang, PhD, Vice President of Biology, Shanghai Medicilon, Inc.       

  

Networking

5:00 PM – 6:00 PM

  

Gala Dinner (Invitation Only)

6:00 PM – 9:30 PM

Grand Ballroom

Gala Host:

Jing Yang,PhD, Senior Principal Scientist, Bristol-Myers Squibb Company

Fang Shen, PhD, Principal Scientist, Janssen R&D 

6:00 PM – 6:05 PM   Special Remarks

Jijun Xing, PhD, Science and Technology Counselor, Chinese Consulate-General in New York 

6:05 PM – 6:35 PM   Guest Presentation

Dengxi Wang, MS, Deputy Secretary, CPC Xinxiang Municipal Committee and Mayor, Xinxiang Municipal People’s Government 

6:35 PM – 6:50 PM   Year-end Remarks

Bin Shi, PhD, President, SAPA‐GP; Head of External R&D/Licensing, Amgen Asia R&D Center 

 

6:50 PM – 6:55 PM   SAPA-GP 2017-2018 Plan and Presidential Election Result

Zhenhua Wu, PhD, President-Elect, SAPA-GP; Associate Director, GlaxoSmithKline 

6:55 PM – 9:30 PM   Dinner and Networking

June 24th, 2017, Saturday

7:30 AM - 8:30 AM   Check-in and Continental Breakfast

8:30 AM - 8:35 AM  Welcome Remarks

Zhenhua Wu, PhD, President-Elect, SAPA-GP; Associate Director, GlaxoSmithKline 

Featured Presentation

8:35 AM - 9:25 AM 

Grand Ballroom

8:35 AM - 9:00 AM   Kelun- Scientific Truth— Seeking, Ethics for Good

Jingyi Wang,MD, PhD, President of Kelun Pharmaceutical Research Institute 

9:00 AM – 9:25 AM   Situation and Present Policies of China’s Pharmaceutical Industry

Mingde Yu, Honorary President and Chair of Expert Committee, China Pharmaceutical Enterprise Association

Plenary Session II

9:30 AM - 10:30 AM 

Grand Ballroom

Innovative Medicines: Transforming Patient Care

 Session Chairs:

Yongchao Su, PhD, Associate Principal Scientist, Merck & Co.

Hanghang Zhang, PhD Candidate, Fels Institute of Cancer Research, Temple University 

9:30 AM - 10:00 AM   Together to Create a World Without Lung Cancer     

Li Mao, MD, Vice President and Head of the Johnson & Johnson China Lung Cancer Center 

10:00 AM - 10:30 AM   Engineering the Environment of the Gut to Treat Inflammatory Bowel Disease      

Gary D. Wu, MD, Ferdinand G. Weisbrod Professor in Gastroenterology, University of Pennsylvania, School of Medicine

10:30 AM - 10:45 AM   Coffee Break

 

Workshop II

10:45 AM - 12:15 PM 

Centennial Ballroom III

Regulatory and Market Access

Regulatory Pathways for Bringing Innovative Products to Markets: Addressing the Needs of Patients and Payers

Session Chairs:

Jim Wang, PhD, MBA, Head of Regulatory Affairs Strategy, Spark Therapeutics, Inc.

Yufeng Li, PhD, Clinical Scientist, GlaxoSmithKline 

10:45 AM - 11:15 AM   Orphan Product Development from First-in-Human Study to Regulatory Approval

Jim Wang, PhD, MBA, Head of Regulatory Affairs Strategy, Spark Therapeutics, Inc. 

11:15 AM - 11:45 AM   Development of Target Product Profile and Product Labeling

Paul Savidge, JD, MBA,Senior Regulatory Counsel, Spark Therapeutics, Inc. 

11:45 AM - 12:15 PM   Health Outcome Analysis for Payer Endorsement

Kim Gilchrist, MD, MBA,Senior Director, Value Evidence & Outcomes, GlaxoSmithKline  

Workshop III

10:45 AM - 12:15 PM 

Centennial Ballroom II

Perspectives of Biopharma R&D in China

 

Session chairs:

John Xu, MD, MBA, MS, Senior Vice President of Strategic Alliance, Abpro

Mengjie Si, PhD Candidate, School of Pharmacy, Temple University 

10:45 AM - 11:15 AM   Pharmaceutic R&D in China: Opportunities and Challenges and Keys to Managing a MNC R&D Center in China

Ming-Qiang Zhang,PhD, Vice President of R&D, Head of Amgen Asia R&D Center 

11:15 AM - 11:45 PM   Innovative Drug R& D in China: HengRui’s Experience and Perspectives

Weikang Tao, PhD, CEO of R&D Centers, Vice President, Jiangsu Hengrui Medicine Co., Ltd. 

VIP Session D

9:30 AM - 12:00 PM 

Haverford

Pharma/Healthcare Global Deal Dynamics Forum

Mergers and Acquisitions (M&A), Investment, and Business Development (BD)

 

Session Chairs:             

Patrick Deng, MBA, Finance Director, Johnson & Johnson

Michael Tang, JD, Tax Associate, EY 

9:30 AM - 10:00 AM   M&A and BD to Drive Exceptional Growth in Pharma/Generic Business

Jie Liu, MBA,Managing Director, New York Office, Torreya Partners 

10:00 AM - 10:30 AM   Deal Structure and Legal Considerations in Cross-border M&A and Investment Deals

Liang Xu, LLM,Partner, Hogan Lovells International 

10:30 AM - 11:00 AM   China Inbound M&A: Valuation Drivers & Tax Impacts

Min Fei, MS, Partner and China Tax Desk Leader, International Tax Services, EY

Yudan Zhang, CPA, MSA, Senior Manager, Transaction Advisory Services, EY 

11:00 AM - 11:30 AM   Coffee Break 

11:30 AM - 12:00 PM   The Cultural and Legal Challenges for Chinese Companies Doing Acquisition or Investment Deals in the US

Zhiping Liu, JD,Partner,Liu, Zheng, Chen & Hoffman LLP

Yong Chen, JD, PhD,Partner,Liu, Zheng, Chen & Hoffman LLP 

VIP Session E

9:30 AM – 12:00 PM, 1:30 PM - 3:30 PM

Centennial Ballroom I

SAPA-Hopkins Venture Forum

 

SAPA-Hopkins Venture Forum is a joint event proudly organized by Sino-American Pharmaceutical Professional Association-Great Philadelphia(SAPA-GP) and The Hopkins Club for Innovation and Entrepreneurship (The Hopkins Club). The forum brings together pharma and biotech leaders, emerging fast-growing companies, technology innovators, and members of the investment community with a focus on biohealth innovation and assets.

9:30 AM – 12:00 PM

Session Chair:

Ying(Charles) Wang, PhD, Scientific Director, GlaxoSmithKline

Zhen Lu, PhD, Application Scientist, Flarebio 

1:30 PM - 3:30 PM

Session Chair:

Han Dai, PhD, Scientific Leader, GSK Fellow, GlaxoSmithKline

Jiayi Zhang, PhD, Scientist, Paragon Bioservices 

Selected Portfolio Companies:

Harborgen Biotechnology, Renman Therapeutics LLC, Beta Biosciences, Inc., Center for Applied System Biology, Inc., TeraImmune LLC, B&H Biotechnologies LLC, DaVinci Healthx, Inc., Anson Diagnostics, Inc, Cosmos Insight LLC, LINKSciences

 

Lunch

11:45 AM - 12:45 PM

Lunch Session

12:15 PM - 1:15 PM

Aiming for Success: Biotechnology Entrepreneurship Boot Camp

Ardmore

Session chair: Xianhua Li, PhD Candidate, Villanova University, Department of Chemical Engineering

Speaker: Dennis Gross, PhD, CEO and Treasurer, Pennsylvania Drug Discovery Institute 

Six Key Successful Retirement Strategies

Paoli

Session chair: Yutai Li, PhD, Principal Scientist, Merck & Co.

Speaker: Carolyn Choh,MBA, Investment Adviser Representative with Financial Independence Planning, LLC.  

Harry Keller, CFP®, ChFC, CLU, MBA, CEO and Founder of Financial Independence Planning, LLC

Executive Development Programs: A Gateway to Leadership Excellence

Frazer

 Session chair: Hui Wang, PhD, Application Scientist, LINKSciences 

Speaker:Gaëlle Beltran-Grémaud, MBA, Senior Director, Aresty Institute of Executive Education, Wharton School, University of Pennsylvania

Michael Malefakis, MIA, Associate Vice Dean, Aresty Institute of Executive Education, Wharton School, University of Pennsylvania 

Latest Developments in PIV Litigation and New Opportunities for Obtaining Generic Exclusivity

 

Devon

 Session Chair: Dan Tian, PhD, University of the Sciences

Speaker: Stephen Yang, JD,Senior Associate, Alston & Bird LLP

Thomas J. Parker, JD, Partner, Alston & Bird LLP

Workshop IV

1:30 PM - 3:30 PM 

Centennial Ballroom III

Navigating through the Changing Regulatory Environment

CMC, Regulatory, Legal and Data Integrity Aspects of Bioequivalence studies

Session Chairs:

Lu Wang, PhD, Senior Scientist, Teva Pharmaceuticals

Chengwei Fang, PhD, Principal Investigator, DuPont Crop Protection 

1:30 PM - 2:00 PM   BA and BE Overview

Bangqian Xu,PhD, Chief Operating Officer, Oryza Pharmaceuticals Inc. 

2:00 PM - 2:30 PM   BE Study: Its Applications in Pharmaceutical Industry

Daniel Du, MD, PhD, Vice President of Clinical Services at Frontage Clinical Services, Inc. 

2:30 PM - 3:00 PM   Coffee Break 

3:00 PM - 3:30 PM   ANDA Filing, Hatch Waxman Litigation, and Post Grant Patent Challenge

Jason Luo, JD, PhD,Patent Attorney, Duane Morris LLP 

 

Workshop V

1:30 PM - 3:30 PM 

Centennial Ballroom II

Biosimilar Development: Strategies and Requirements

 

Session Chairs:

Yu Gao, MS, Research Associate, Teva pharmaceuticals

Yang Liu, PhD, Investigator, GlaxoSmithKline 

1:30 PM - 2:00 PM   Demonstration of Biosimilarity

Patrick Liu, MD, PhD, Vice President of Biologics R&D and Head of Global Bioassays and Technology, Teva Pharmaceuticals 

2:00 PM - 2:30 PM   Biosimilar Exclusivity and Interchangeability: A Legal Primer

Xin Tao, JD, Senior Associate, Hogan Lovells US LLP 

2:30 PM - 3:00 PM   Coffee Break

3:00 PM - 3:30 PM   Biosimilar Development in the US from Quality and Regulatory Perspective

Audrey Jia, PhD, Independent Consultant 

Workshop VI

1:30 PM - 3:30 PM 

Harverford

Current Trends and Future Directions of Clinical Trial Designs and Regulatory Science

In US and China

Session Chairs:

Shuang (Steve)Wu, PhD, MS Candidate in Biostatistics, Columbia University

Hao Wu, PhD, Technical Specialist, Howson & Howson, LLP 

1:30 PM - 2:00 PM   ICH 17 and Global Drug Development

William(Bill) Wang, PhD, Executive Director, Clinical Safety Statistics, Biostatistics and Research Decision Sciences(BARDS), Merck Research Laboratories 

2:00 PM - 2:30 PM   Safety Issues in Clinical Trials

Huabin Sun, MD, Medical Safety Officer/Director, Global Medical Safety, Janssen R&D 

2:30 PM - 3:00 PM   Coffee Break 

3:00 PM - 3:30 PM   In parallel Development of Clinical Programs in US and China 

Simon Li, MD, PhD, Chief Medical Officer, Vice President of CSPC Pharma 

 

3:30 PM - 3:35 PM   Closing Remarks                                                                                    Grand Ballroom

Zhenhua Wu, PhD, President-Elect, SAPA-GP; Associate Director, GlaxoSmithKline

 

3:35 PM – 3:45 PM   Raffle Drawing                                                                                       Grand Ballroom

Hui Wang, PhD, Application Scientist, LINKSciences